Rallybio Corporation (NASDAQ:RLYB) Shareholders to Collect $13.56 Special Dividend

Rallybio Corporation (NASDAQ:RLYB) declared a special dividend on Sunday, October 25th. Stockholders of record on Thursday, November 5th will be given a dividend of $13.56 per share on Friday, November 13th.

Rallybio Stock Down 4.3%

Shares of Rallybio stock traded down $0.72 on Tuesday, hitting $15.93. 52,619 shares of the company traded hands, compared to its average volume of 123,699. Rallybio has a 12-month low of $3.67 and a 12-month high of $17.57. The company has a market cap of $84.59 million, a PE ratio of -3.67 and a beta of -0.72. The company has a 50-day moving average price of $16.82 and a 200 day moving average price of $12.67.

Rallybio (NASDAQ:RLYB) last announced its quarterly earnings data on Tuesday, October 27th. The company reported ($0.48) earnings per share (EPS) for the quarter. Rallybio had a negative return on equity of 40.53% and a negative net margin of 911.07%.

Rallybio Company Profile

Rallybio Corporation is a clinical-stage biotechnology company focused on developing medicines for patients with rare diseases, with an emphasis on conditions that affect maternal and fetal health, as well as other serious disorders with limited treatment options. The company is headquartered in New Haven, Connecticut, and its programs are intended for specialized patient populations in the United States and international markets.

Rallybio’s lead program, RLYB212, is being developed to prevent fetal and neonatal alloimmune thrombocytopenia, a rare condition in which maternal antibodies attack fetal platelets during pregnancy.